Group One Trading
CPRX

Group One Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Group One Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48K Buy
+100
New +$2.38K ﹤0.01% 6981
2025
Q4 		– Sell
-300
Closed -$5.91K – 8263
2025
Q3 		$5.91K Sell
300
-500
-63% -$10.3K ﹤0.01% 7460
2025
Q2 		$17.4K Buy
800
+300
+60% +$7.08K ﹤0.01% 6364
2025
Q1 		$12.1K Buy
+500
New +$11.3K ﹤0.01% 6133
2024
Q4 		– Sell
-25,400
Closed -$505K – 7368
2024
Q3 		$505K Sell
25,400
-4,800
-16% -$89K ﹤0.01% 2854
2024
Q2 		$468K Buy
30,200
+15,500
+105% +$241K ﹤0.01% 2621
2024
Q1 		$234K Sell
14,700
-50,200
-77% -$756K ﹤0.01% 3421
2023
Q4 		$1.09M Buy
64,900
+61,200
+1,654% +$837K ﹤0.01% 2392
2023
Q3 		$43.3K Sell
3,700
-21,400
-85% -$286K ﹤0.01% 5239
2023
Q2 		$337K Buy
25,100
+22,000
+710% +$317K ﹤0.01% 3419
2023
Q1 		$51.4K Buy
3,100
+2,500
+417% +$41.2K ﹤0.01% 4826
2022
Q4 		$11.2K Sell
600
-12,600
-95% -$194K ﹤0.01% 5976
2022
Q3 		$169K Buy
+13,200
New +$156K ﹤0.01% 4302
2022
Q2 		– Sell
-1,000
Closed -$8K – 7910
2022
Q1 		$8K Buy
1,000
+900
+900% +$6.36K ﹤0.01% 7236
2021
Q4 		$1K Sell
100
-47,800
-100% -$314K ﹤0.01% 7972
2021
Q3 		$254K Sell
47,900
-9,900
-17% -$54.1K ﹤0.01% 4921
2021
Q2 		$332K Buy
57,800
+52,900
+1,080% +$273K ﹤0.01% 4679
2021
Q1 		$23K Buy
4,900
+3,000
+158% +$11.9K ﹤0.01% 6694
2020
Q4 		$6K Buy
+1,900
New +$6.38K ﹤0.01% 5956
2020
Q3 		– Sell
-4,000
Closed -$18K – 6133
2020
Q2 		$18K Sell
4,000
-200
-5% -$899 ﹤0.01% 4868
2020
Q1 		$16K Sell
4,200
-12,000
-74% -$49.3K ﹤0.01% 4341
2019
Q4 		$61K Sell
16,200
-17,600
-52% -$82.3K ﹤0.01% 3917
2019
Q3 		$179K Sell
33,800
-31,200
-48% -$166K ﹤0.01% 3159
2019
Q2 		$250K Buy
65,000
+1,100
+2% +$4.75K ﹤0.01% 2682
2019
Q1 		$326K Buy
63,900
+19,500
+44% +$57.3K ﹤0.01% 2297
2018
Q4 		$85K Buy
44,400
+24,600
+124% +$70.4K ﹤0.01% 3274
2018
Q3 		$75K Buy
+19,800
New +$62K ﹤0.01% 3722
2018
Q2 		– Sell
-5,000
Closed -$12K – 5147
2018
Q1 		$12K Hold
5,000
– – ﹤0.01% 4255
2017
Q4 		$20K Sell
5,000
-16,900
-77% -$55.8K ﹤0.01% 4151
2017
Q3 		$55K Sell
21,900
-4,700
-18% -$12.9K ﹤0.01% 3580
2017
Q2 		$73K Buy
+26,600
New +$55.5K ﹤0.01% 3303
2015
Q3 		– Sell
-500
Closed -$2K – 4899
2015
Q2 		$2K Buy
+500
New +$1.99K ﹤0.01% 4658
2015
Q1 		– Sell
-15,600
Closed -$46K – 4820
2014
Q4 		$46K Sell
15,600
-16,700
-52% -$45.8K ﹤0.01% 3420
2014
Q3 		$107K Buy
32,300
+26,400
+447% +$69K ﹤0.01% 2916
2014
Q2 		$15K Buy
5,900
+5,300
+883% +$11.3K ﹤0.01% 4323
2014
Q1 		$1K Sell
600
-600
-50% -$1.25K ﹤0.01% 5058
2013
Q4 		$2K Buy
+1,200
New +$2.43K ﹤0.01% 5047

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CPRX Position: Q4 2024 in Review

Group One Trading sold out of Catalyst Pharmaceutical (CPRX) in Q4 2024, closing a stake of 8,108 shares — an estimated $174K sold.

Group One Trading first reported a position in CPRX in Q4 2013 and held it in 21 quarters. The position peaked at $992K in Q3 2019. 336 funds tracked by Wall St. Rank hold CPRX as of Q4 2024.

  • Group One Trading reported no remaining Catalyst Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 8,108 Catalyst Pharmaceutical shares in Q4 2024, an estimated $174K.
  • Group One Trading first reported a position in Catalyst Pharmaceutical in Q4 2013 and held it in 21 quarters.
  • Group One Trading's Catalyst Pharmaceutical position peaked at $992K in Q3 2019.
  • 336 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.